 |
|
Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Yu-Ning Wong, MD;
Nandita Mitra, PhD;
Gary Hudes, MD;
Russell Localio, PhD;
J. Sanford Schwartz, MD;
Fei Wan, MS;
Chantal Montagnet, MA, MPhil;
Katrina Armstrong, MD, MSCE
JAMA. 2006;296:2683-2693.
Context Prostate-specific antigen screening has led to an increase in the diagnosis and treatment of localized prostate cancer. However, the role of active treatment of low- and intermediate-risk disease in elderly men is controversial.
Objective To estimate the association between treatment (with radiation therapy or radical prostatectomy) compared with observation and overall survival in men with low- and intermediate-risk prostate cancer.
Design and Setting Observational US cohort from Surveillance, Epidemiology, and End Results Medicare data.
Patients At total of 44 630 men aged 65 to 80 years who were diagnosed between 1991 and 1999 with organ-confined, well- or moderately differentiated prostate cancer and who had survived more than a year past diagnosis. Patients were followed up until death or study end (December 31, 2002). Patients were classified as having received treatment (n=32 022) if they had claims for radical prostatectomy or radiation therapy during the first 6 months after diagnosis. They were classified as having received observation (n=12 608) if they did not have claims for radical prostatectomy, radiation, or hormonal therapy. Patients who received only hormonal therapy were excluded.
Main Outcome Measure Overall survival.
Results At the end of the 12-year study period, 4663 men (37%) in the observational group and 7639 men (23.8%) in the treatment group had died. The treatment group had longer 5- and 10-year survival than the observation group. After using propensity scores to adjust for potential confounders (tumor characteristics, demographics, and comorbidities), there was a statistically significant survival advantage associated with treatment (hazard ratio, 0.69; 95% confidence interval, 0.66-0.72). A benefit associated with treatment was seen in all subgroups examined, including older men (aged 75-80 years at diagnosis), black men, and men with low-risk disease.
Conclusions This study suggests a survival advantage is associated with active treatment for low- and intermediate-risk prostate cancer in elderly men aged 65 to 80 years. Because observational data cannot completely adjust for potential selection bias and confounding, these results must be validated in randomized controlled trials of alternative management strategies in elderly men with localized prostate cancer.
Author Affiliations: Divisions of Population Science (Dr Wong) and Medical Science (Drs Wong and Hudes), Fox Chase Cancer Center; Department of Biostatistics and Epidemiology (Drs Mitra and Localio), Division of General Internal Medicine (Drs Schwartz and Armstrong and Mr Wan and Ms Montagnet), and Abramson Cancer Center and Leonard Davis Institute of Health Economics (Drs Schwartz and Armstrong), University of Pennsylvania, Philadelphia.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Grace L. Lu-Yao, Michael J. Barry, Peter C. Albertsen, and Siu-Long Yao
JAMA. 2007;297(15):1651.
EXTRACT
| FULL TEXT
Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Mark C. Scholz, Richard Y. Lam, and Laurence Klotz
JAMA. 2007;297(15):1651-1652.
EXTRACT
| FULL TEXT
Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men
George A. Mark
JAMA. 2007;297(15):1652.
EXTRACT
| FULL TEXT
Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Michael P. Porter
JAMA. 2007;297(15):1652.
EXTRACT
| FULL TEXT
Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men—Reply
Yu-Ning Wong, Nandita Mitra, Gary Hudes, J. Sanford Schwartz, Fei Wan, Chantal Montagnet, and Katrina Armstrong
JAMA. 2007;297(15):1652-1653.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Treating Older Men With Prostate Cancer: Survival (or Selection) of the Fittest?
Mark S. Litwin and David C. Miller
JAMA. 2006;296(22):2733-2734.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
A 64-Year-Old Man With Low-Risk Prostate Cancer: Review of Prostate Cancer Treatment
Sanda and Kaplan
JAMA 2009;301:2141-2151.
ABSTRACT
| FULL TEXT
Patients' Survival Expectations before Localized Prostate Cancer Treatment by Treatment Status
Mohan et al.
J Am Board Fam Med 2009;22:247-256.
ABSTRACT
| FULL TEXT
Prostate-Specific Antigen Testing among the Elderly in Community-Based Family Medicine Practices
Hudson et al.
J Am Board Fam Med 2009;22:257-265.
ABSTRACT
| FULL TEXT
Management of Prostate Cancer
NEJM 2008;359:2605-2609.
FULL TEXT
Profile-specific survival estimates: Making reports of clinical trials more patient-relevant
Julien and Hanley
Clin Trials 2008;5:107-115.
ABSTRACT
Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer
Wilt et al.
ANN INTERN MED 2008;148:435-448.
ABSTRACT
| FULL TEXT
Short- and Long-term Mortality With Localized Prostate Cancer
Merglen et al.
Arch Intern Med 2007;167:1944-1950.
ABSTRACT
| FULL TEXT
Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Lu-Yao et al.
JAMA 2007;297:1651-1651.
FULL TEXT
Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Mark
JAMA 2007;297:1652-1652.
FULL TEXT
Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Scholz et al.
JAMA 2007;297:1651-1652.
FULL TEXT
Outcomes of Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Porter
JAMA 2007;297:1652-1652.
FULL TEXT
Response: Re: Detection of Life-Threatening Prostate Cancer With Prostate-Specific Antigen Velocity During a Window of Curability
Carter et al.
JNCI J Natl Cancer Inst 2007;99:490-490.
FULL TEXT
Therapy Options in Older Men with Prostate Cancer
JWatch Oncology and Hematology 2007;2007:2-2.
FULL TEXT
Treating Older Men With Prostate Cancer: Survival (or Selection) of the Fittest?
Litwin and Miller
JAMA 2006;296:2733-2734.
FULL TEXT
Treatment vs. Observation in Older Men with Localized Prostate Cancer
JWatch General 2006;2006:1-1.
FULL TEXT
|
